Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back
Benzinga·2025-12-17 15:14

Pfizer Inc (NYSE:PFE) and Merck & Co Inc (NYSE:MRK) aren't exciting stocks anymore — and after a bruising reset, that's starting to look intentional. Pfizer's stock has been back in focus this month after the company laid out a cautious 2026 outlook, acknowledging that the post-COVID reset isn't over yet. Track PFE stock here.Management flagged flat-to-low single-digit growth expectations, with COVID product declines continuing to fade out of the base. The market's response was telling: shares slipped, but ...